Page last updated: 2024-09-02

fingolimod hydrochloride and Puerperal Disorders

fingolimod hydrochloride has been researched along with Puerperal Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berenguer-Ruiz, L; Gimenez-Martinez, J; Palazón-Bru, A; Sempere, AP	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Puerperal Disorders

Article	Year
Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy. Journal of neurology, 2019, Volume: 266, Issue:10 Topics: Adult; Disease Progression; Female; Fingolimod Hydrochloride; Follow-Up Studies; Glatiramer Acetate; Humans; Immunologic Factors; Interferon-beta; Multiple Sclerosis; Natalizumab; Pregnancy; Pregnancy Complications; Puerperal Disorders; Recurrence; Reproductive Behavior	2019

Article

Year

Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.

Journal of neurology, 2019, Volume: 266, Issue:10

Topics: Adult; Disease Progression; Female; Fingolimod Hydrochloride; Follow-Up Studies; Glatiramer Acetate; Humans; Immunologic Factors; Interferon-beta; Multiple Sclerosis; Natalizumab; Pregnancy; Pregnancy Complications; Puerperal Disorders; Recurrence; Reproductive Behavior

2019